Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatment
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference27 articles.
1. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial;Krag;Lancet Oncol,2007
2. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial;Krag;Lancet Oncol,2010
3. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study;Veronesi;Ann Surg,2010
4. Summary of the guideline ’Sentinel node biopsy in breast cancer’. Dutch Work Group ‘Sentinel Node Biopsy for Breast Cancer’’;Roumen;Ned Tijdschr Geneeskd,2000
5. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands;Ho;Eur J Cancer (Oxford, England: 1990),2008
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Survival benefits of postoperative radiotherapy in patients with cT1 − 2N1M0 breast cancer after neoadjuvant chemotherapy: a SEER-based population study;BMC Women's Health;2024-06-05
2. Research hotspots and frontiers of neoadjuvant therapy in triple negative breast cancer: A bibliometric analysis of publications between 2002 and 2023;International Journal of Surgery;2024-05-13
3. The Feasibility and Reliability of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Negative Axillary Lymph Nodes—A Meta-analysis;Breast Cancer: Basic and Clinical Research;2024-01
4. Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon;Cancer Medicine;2023-12-22
5. Adjuvant radiotherapy may not confer survival benefit for cT1-2N1M0 breast cancer patients who undergo surgical treatment following neoadjuvant chemotherapy: an analysis based on SEER;2023-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3